Is triple therapy redefining first-line treatment in intermediate-advanced hepatocellular carcinoma?
Saved in:
| Title: | Is triple therapy redefining first-line treatment in intermediate-advanced hepatocellular carcinoma? |
|---|---|
| Authors: | Obi S; Department of Internal Medicine, Teikyo University Chiba Medical Center, 3426-3 Anesaki, Ichihara, Chiba, 299-0111, Japan. obis@med.teikyo-u.ac.jp., Omata M; Department of Gastroenterology, Yamanashi Prefectural Central Hospital, Yamanashi, Japan.; The University of Tokyo, Tokyo, Japan. |
| Source: | Hepatology international [Hepatol Int] 2026 Apr 19. Date of Electronic Publication: 2026 Apr 19. |
| Publication Type: | Editorial |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 101304009 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1936-0541 (Electronic) Linking ISSN: 19360533 NLM ISO Abbreviation: Hepatol Int Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1936-0541 |
|---|---|
| DOI: | 10.1007/s12072-026-11089-1 |
